Bausch Health Companies Inc [NYSE: BHC] loss -0.51% or -0.03 points to close at $5.87 with a heavy trading volume of 9671568 shares.
The daily chart for BHC points out that the company has recorded -37.49% loss over the past six months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If we look at the average trading volume of 3.39M shares, BHC reached to a volume of 9671568 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Bausch Health Companies Inc [BHC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BHC shares is $7.64 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BHC stock is a recommendation set at 3.14. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Bausch Health Companies Inc shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on August 02, 2024. While these analysts kept the previous recommendation, Raymond James raised their target price to Mkt Perform. The new note on the price target was released on July 10, 2024, representing the official price target for Bausch Health Companies Inc stock. Previously, the target price had yet another raise from $9 to $16, while Jefferies kept a Buy rating on BHC stock.
The Average True Range (ATR) for Bausch Health Companies Inc is set at 0.26, with the Price to Sales ratio for BHC stock in the period of the last 12 months amounting to 0.23. Price to Free Cash Flow for BHC in the course of the last twelve months was 2.36 with Quick ratio for the last quarter at 0.82.
Trading performance analysis for BHC stock
Bausch Health Companies Inc [BHC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.73. With this latest performance, BHC shares dropped by -2.65% in over the last four-week period, additionally sinking by -37.49% over the last 6 months – not to mention a drop of -30.78% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BHC stock in for the last two-week period is set at 46.87, with the RSI for the last a single of trading hit 51.39, and the three-weeks RSI is set at 44.73 for Bausch Health Companies Inc [BHC]. The present Moving Average for the last 50 days of trading for this stock 6.41, while it was recorded at 5.91 for the last single week of trading, and 7.60 for the last 200 days.
Bausch Health Companies Inc [BHC]: A deeper dive into fundamental analysis
Bausch Health Companies Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.82 and a Current Ratio set at 1.19.
Bausch Health Companies Inc [BHC]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Bausch Health Companies Inc posted 1.02/share EPS, while the average EPS was predicted by analysts to be reported at 0.92/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.1. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BHC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Bausch Health Companies Inc go to 2.60%.
An analysis of Institutional ownership at Bausch Health Companies Inc [BHC]
There are presently around $79.00%, or 79.92%% of BHC stock, in the hands of institutional investors. The top three institutional holders of BHC stocks are: ICAHN CARL C with ownership of 34.72 million shares, which is approximately 9.466%. PAULSON & CO. INC., holding 26.44 million shares of the stock with an approximate value of $$184.28 million in BHC stocks shares; and PAULSON & CO. INC., currently with $$156.39 million in BHC stock with ownership which is approximately 6.117%.
